Intraovarian insertion of autologous platelet growth factors as cell-free concentrate: Fertility recovery and first unassisted conception with term delivery at age over 40
Background: The use of autologous platelet-rich plasma as an ovarian treatment has not been standardized and remains controversial. Case Presentation: A 41½-year old woman with diminished ovarian reserve (serum anti- Müllerian hormone = 0.163 mg/mL) and a history of 10 unsuccessful in vitro fertiliz...
Main Authors: | E. Scott Sills, Natalie S. Rickers, Samuel H. Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Sadoughi University of Medical Sciences
2020-12-01
|
Series: | International Journal of Reproductive BioMedicine |
Subjects: | |
Online Access: | https://doi.org/10.18502/ijrm.v18i12.8030 |
Similar Items
-
Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women
by: Konstantinos Sfakianoudis, et al.
Published: (2020-06-01) -
Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation
by: Shahin Ahmadian, et al.
Published: (2020-08-01) -
Intraovarian platelet-rich plasma: current status
by: Aboubakr Mohamed Elnashar
Published: (2021-08-01) -
An introduction to application of Platelet Rich Plasma (PRP) in skin rejuvenation
by: Mahnaz Banihashemi, et al.
Published: (2014-04-01) -
Evaluation of Perioral Skin Rejuvenation with Platelet – Rich Plasma
by: Suha Aloosi, et al.
Published: (2020-12-01)